✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

JFL Life Sciences Ltd.

JFLLIFE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹46 Cr.
P/E
10.95

JFL Life Sciences Ltd.

  • JFL Life Sciences
  • Dipna Pharma.
  • Deccan Health Care

FAQs on JFL Life Sciences Ltd. Shareprice

JFL Life Sciences has given better returns compared to its competitors.
JFL Life Sciences has grown at ~-3.1% over the last 3yrs while peers have grown at a median rate of -12.12%

JFL Life Sciences is not expensive.
Latest PE of JFL Life Sciences is 10.95, while 3 year average PE is 20.05.
Also latest EV/EBITDA of JFL Life Sciences is 7.33 while 3yr average is 11.06.

View FAQ's On Business

Growth Table

  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Balance Sheet

  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Cash Flow

  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Quarterly Results

  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on JFL Life Sciences Ltd. Financials

Balance sheet of JFL Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of JFL Life Sciences is increasing.
Latest net debt of JFL Life Sciences is ₹10.47 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹4.84 Crs.

The profit is oscillating.
The profit of JFL Life Sciences is ₹3.49 Crs for TTM, ₹4.16 Crs for Mar 2025 and ₹3.31 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
JFL Life Sciences latest dividend payout ratio is 8.33% and 3yr average dividend payout ratio is 8.33%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech